Loading...

LONGEVITY HEALTH HOLDINGS INC Capital Structure Changes 8-K Filing

LNGV

LONGEVITY HEALTH HOLDINGS INC

()

2026 8-K

Stock Purchase Agreement

Merger Termination

Merger Agreement Update

Nasdaq Delisting

Merger of Equals

Merger of Equals

Asset Acquisitions

Merger of Equals

Merger of Equals

Reverse Stock Split

Merger Agreement

Delisting Notice

Asset Acquisition

Stockholder Meeting

Asset Acquisition

Asset Acquisition

Securities Agreement

Investor Presentation

Nasdaq Compliance Notice

Nasdaq Compliance Notice

Management Change

Annual Meeting of Stockholders

Securities Purchase Agreement

Completion of Asset Sale

Agreement for Sale of AxoBio

Management Change

Management Appointment

Management Appointment

Management Appointment

Management Addition

Management Appointment

Management Appointment

Appointment of CEO

Appointment of Directors

Acquisition of Axolotl Biol...

Acquisition Completion

Merger Agreement

Asset Acquisitions

Acquisition Announcement

Investor Notification

Business Combination Agreement

External Links:

On March 13, 2026, Longevity Health Holdings, Inc. agreed to sell 689,656 shares of common stock at $0.29 each for approximately $200,000 to International Capital Partners, with the closing on March 16, 2026; Janakiram Ajjarapu was appointed CEO on the same date, while Rajiv S. Shukla stepped down as CEO and chairman.

AI Assistant

LONGEVITY HEALTH HOLDINGS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.